1-3 of 3
Jeffrey Trocio, MPH
Close
Sort by
Journal Articles

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Amin N Alpesh, MBA, MD, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Kwanza Price, MPH, Lien Vo, MPH, PharmD, Prianka Singh, PharmD, Amanda Bruno, MPH, PhD, Jack Mardekian, PhD, Wilson Tan, MRCS, MD, Shalabh Singhal, MD, Chad Patel, PharmD, Kevin Odell, PharmD, Jeffrey Trocio, MPH
Journal: Blood
Blood (2015) 126 (23): 745.
https://doi.org/10.1182/blood.V126.23.745.745
Published: 2015
Journal Articles

Estimate of Real-World Medical Costs Avoidance When New Oral Anticoagulants Are Used Vs. Standard Therapy for the Treatment of Patients with Venous Thromboembolism in the U.S

Alpesh N Amin, MDMBA, Amanda Bruno, PhD MPH, Jeffrey Trocio, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD
Journal: Blood
Blood (2014) 124 (21): 687.
https://doi.org/10.1182/blood.V124.21.687.687
Published: 2014
Journal Articles

Comparison of Medical Costs Avoided When New Oral Anticoagulants Are Used for the Treatment of Patients with Atrial Fibrillation and Venous Thromboembolism in the U.S

Alpesh N Amin, MDMBA, Amanda Bruno, PhD MPH, Jeffrey Trocio, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD
Journal: Blood
Blood (2014) 124 (21): 2181.
https://doi.org/10.1182/blood.V124.21.2181.2181
Published: 2014